FFCP PHASE2:Hg19::chr2:152146128..152146189,-
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p1@NMI |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_NMI_5end |
Coexpression cluster: | NA |
Association with transcript: | 187bp_to_ENST00000477072, ENST00000491771_5end |
EntrezGene: | NMI |
HGNC: | 7854 |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p1@NMI |
---|
0
50
100
150
200
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
hematopoietic stem cell | 3.04e-42 | 168 |
hematopoietic oligopotent progenitor cell | 4.96e-41 | 161 |
hematopoietic multipotent progenitor cell | 4.96e-41 | 161 |
myeloid cell | 1.75e-38 | 108 |
common myeloid progenitor | 1.75e-38 | 108 |
hematopoietic cell | 1.73e-37 | 177 |
leukocyte | 2.52e-27 | 136 |
myeloid leukocyte | 7.26e-25 | 72 |
hematopoietic lineage restricted progenitor cell | 1.26e-23 | 120 |
nongranular leukocyte | 1.41e-23 | 115 |
Showing 1 to 10 of 27 entries
Ontology term | p-value | n |
---|---|---|
hemolymphoid system | 1.77e-24 | 108 |
hematopoietic system | 3.75e-24 | 98 |
blood island | 3.75e-24 | 98 |
immune system | 2.12e-20 | 93 |
bone marrow | 3.85e-18 | 76 |
bone element | 1.17e-15 | 82 |
skeletal element | 9.28e-15 | 90 |
skeletal system | 3.55e-13 | 100 |
connective tissue | 3.83e-12 | 371 |
lateral plate mesoderm | 2.32e-10 | 203 |
Showing 1 to 10 of 10 entries
Ontology term | p-value | n |
---|---|---|
hematologic cancer | 2.06e-20 | 51 |
immune system cancer | 2.06e-20 | 51 |
leukemia | 2.85e-20 | 39 |
myeloid leukemia | 3.29e-17 | 31 |
Showing 1 to 4 of 4 entries